Ascendis Pharma A (ASND) Long-Term Debt Repayments (2023 - 2025)
Historic Long-Term Debt Repayments for Ascendis Pharma A (ASND) over the last 6 years, with Q3 2025 value amounting to -$7.7 million.
- Ascendis Pharma A's Long-Term Debt Repayments fell 14874.93% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.3 million, marking a year-over-year decrease of 6757.58%. This contributed to the annual value of -$12.3 million for FY2024, which is 952.85% down from last year.
- As of Q3 2025, Ascendis Pharma A's Long-Term Debt Repayments stood at -$7.7 million, which was down 14874.93% from -$6.2 million recorded in Q2 2025.
- In the past 5 years, Ascendis Pharma A's Long-Term Debt Repayments registered a high of -$2.4 million during Q1 2021, and its lowest value of -$7.7 million during Q3 2025.
- Over the past 4 years, Ascendis Pharma A's median Long-Term Debt Repayments value was -$3.0 million (recorded in 2024), while the average stood at -$3.6 million.
- Examining YoY changes over the last 5 years, Ascendis Pharma A's Long-Term Debt Repayments showed a top increase of 655.76% in 2025 and a maximum decrease of 14874.93% in 2025.
- Over the past 4 years, Ascendis Pharma A's Long-Term Debt Repayments (Quarter) stood at -$2.4 million in 2021, then dropped by 24.34% to -$2.9 million in 2023, then dropped by 7.02% to -$3.1 million in 2024, then tumbled by 143.93% to -$7.7 million in 2025.
- Its Long-Term Debt Repayments stands at -$7.7 million for Q3 2025, versus -$6.2 million for Q2 2025 and -$3.2 million for Q1 2025.